Author

G. Rona

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:chromatin & epigenetic regulation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

M. Pagano· 2 shared A. A. Wang· 1 shared A. Bekesi· 1 shared A. Poti· 1 shared A. Thomas· 1 shared B. G. Vertessy· 1 shared B. Gyorffy· 1 shared B. Miwatani-Minter· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

M. Pagano

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

D-type cyclins regulate DNA mismatch repair in the G1 and S phases of the cell cycle, maintaining genome stability

G. Rona, B. Miwatani-Minter, Q. Zhang, H. V. Goldberg, M. A. Kerzhnerman, J. B. Howard, D. Simoneschi, E. Lane, J. W. Hobbs, E. Sassani, A. A. Wang, S. Keegan, D. J. Laverty, C. G. Piett, L. S. Pongor, , M. Pagano

This study shows D-type cyclins inhibit mismatch repair (MMR) in G1 phase by shielding p21, while their degradation in S phase enables proper MMR function, maintaining genome stability.

bioRxiv · Jan 12, 2024Cell Biology

Genome-wide alterations of uracil distribution patterns in human DNA upon chemotherapeutic treatments

H. L. Palinkas, A. Bekesi, G. Rona, L. Pongor, G. Tihanyi, E. Holub, A. Poti, C. Gemma, S. Ali, M. J. Morten, E. Rothenberg, M. Pagano, D. Szuts, B. Gyorffy, B. G. Vertessy

The paper investigates genome-wide uracil distribution changes in human cells after chemotherapy, finding drug-induced shifts toward active genomic regions.

bioRxiv · Mar 4, 2020Biochemistry